Twist Bioscience Corp.

TWST

$83.58

+283.02% (1 year change)

Avg closing price

Price range

Market Cap

$3.84 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$21.2 Million

Total revenue in the last quarter.

Net Income

$-28.2 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-4.17

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-20.6x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-28.2 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

414

The number of full time employees.

Revenue & Earnings

Balance Sheet

Twist Bioscience Corp.

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

News

Twist Bioscience (NASDAQ:TWST) Stock Rating Lowered by BidaskClub

Twist Bioscience (NASDAQ:TWST) Stock Rating Lowered by BidaskClub

Twist Bioscience (NASDAQ:TWST) was downgraded by equities research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Wednesday, BidAskClu...

Daily Political Daily Political, 6 days ago
Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020

Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using it...

Business Wire Business Wire, 15 days ago
Global Synthetic Biology Market 2020 Industry Outlook: Post COVID Investors Eye Bigger Than Expected||Players-Novozymes, PRECIGEN: Advancing Medicine With Precision, GenScript, Twist Bioscience

Global Synthetic Biology Market 2020 Industry Outlook: Post COVID Investors Eye Bigger Than Expected||Players-Novozymes, PRECIGEN: Advancing Medicine With Precision, GenScript, Twist Bioscience

Synthetic Biology Market Research Report provides in-depth information and professional study 2020-2027 of Synthetic Biology Industry. This Report is segmented into Manufactures, Types, Application...

OpenPR OpenPR, 16 days ago